159 related articles for article (PubMed ID: 37440711)
1. Cognitive function during 3 years of growth hormone in previously growth hormone-treated young adults with Prader-Willi syndrome.
Trueba-Timmermans DJ; Grootjen LN; Juriaans AF; Mahabier EF; Kerkhof GF; Rings EHHM; Hokken-Koelega ACS
Eur J Endocrinol; 2023 Jul; 189(1):132-139. PubMed ID: 37440711
[TBL] [Abstract][Full Text] [Related]
2. Cognitive functioning in children with Prader-Willi syndrome during 8 years of growth hormone treatment.
Donze SH; Damen L; Mahabier EF; Hokken-Koelega ACS
Eur J Endocrinol; 2020 Apr; 182(4):405-411. PubMed ID: 31961800
[TBL] [Abstract][Full Text] [Related]
3. Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.
Damen L; Grootjen LN; Donze SH; Juriaans AF; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2020 Oct; 93(4):439-448. PubMed ID: 32609902
[TBL] [Abstract][Full Text] [Related]
4. Effect of cessation of GH treatment on cognition during transition phase in Prader-Willi syndrome: results of a 2-year crossover GH trial.
Kuppens RJ; Mahabier EF; Bakker NE; Siemensma EP; Donze SH; Hokken-Koelega AC
Orphanet J Rare Dis; 2016 Nov; 11(1):153. PubMed ID: 27852283
[TBL] [Abstract][Full Text] [Related]
5. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
6. Behavior in children with Prader-Willi syndrome before and during growth hormone treatment: a randomized controlled trial and 8-year longitudinal study.
Lo ST; Siemensma EP; Festen DA; Collin PJ; Hokken-Koelega AC
Eur Child Adolesc Psychiatry; 2015 Sep; 24(9):1091-101. PubMed ID: 25522840
[TBL] [Abstract][Full Text] [Related]
7. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
[TBL] [Abstract][Full Text] [Related]
9. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition.
Damen L; Donze SH; Kuppens RJ; Bakker NE; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Orphanet J Rare Dis; 2020 Jun; 15(1):163. PubMed ID: 32580778
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density during 3 years of growth hormone in previously GH-treated young adults with PWS.
Damen L; Grootjen LN; Donze SH; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
Eur J Endocrinol; 2021 May; 184(6):773-782. PubMed ID: 33769952
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of growth hormone treatment on cognition in children with Prader-Willi syndrome: a randomized controlled trial and longitudinal study.
Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Troeman ZC; van Alfen-van der Velden AA; Otten BJ; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Oostdijk W; Bocca G; Mieke Houdijk EC; van Trotsenburg AS; Hoorweg-Nijman JJ; van Wieringen H; Vreuls RC; Jira PE; Schroor EJ; van Pinxteren-Nagler E; Willem Pilon J; Lunshof LB; Hokken-Koelega AC
J Clin Endocrinol Metab; 2012 Jul; 97(7):2307-14. PubMed ID: 22508707
[TBL] [Abstract][Full Text] [Related]
12. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in young adults with Prader-Willi syndrome: A randomized, placebo-controlled, crossover GH trial.
Donze SH; Kuppens RJ; Bakker NE; van Alfen-van der Velden JAEM; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2018 Jun; 88(6):806-812. PubMed ID: 29418016
[TBL] [Abstract][Full Text] [Related]
14. Effects of growth hormone on cognitive, motor, and behavioral development in Prader-Willi syndrome children: a meta-analysis of randomized controlled trials.
Luo Y; Zheng Z; Yang Y; Bai X; Yang H; Zhu H; Pan H; Chen S
Endocrine; 2021 Feb; 71(2):321-330. PubMed ID: 33222122
[TBL] [Abstract][Full Text] [Related]
15. Cognitive and adaptive advantages of growth hormone treatment in children with Prader-Willi syndrome.
Dykens EM; Roof E; Hunt-Hawkins H
J Child Psychol Psychiatry; 2017 Jan; 58(1):64-74. PubMed ID: 27481444
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density in children and adolescents with Prader-Willi syndrome: a longitudinal study during puberty and 9 years of growth hormone treatment.
Bakker NE; Kuppens RJ; Siemensma EP; Tummers-de Lind van Wijngaarden RF; Festen DA; Bindels-de Heus GC; Bocca G; Haring DA; Hoorweg-Nijman JJ; Houdijk EC; Jira PE; Lunshof L; Odink RJ; Oostdijk W; Rotteveel J; Van Alfen AA; Van Leeuwen M; Van Wieringen H; Wegdam-den Boer ME; Zwaveling-Soonawala N; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Apr; 100(4):1609-18. PubMed ID: 25668198
[TBL] [Abstract][Full Text] [Related]
17. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
18. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
[TBL] [Abstract][Full Text] [Related]
19. Two years of growth hormone therapy in young children with Prader-Willi syndrome: physical and neurodevelopmental benefits.
Myers SE; Whitman BY; Carrel AL; Moerchen V; Bekx MT; Allen DB
Am J Med Genet A; 2007 Mar; 143A(5):443-8. PubMed ID: 17103437
[TBL] [Abstract][Full Text] [Related]
20. Effects of 8 years of growth hormone treatment on scoliosis in children with Prader-Willi syndrome.
Grootjen LN; Rutges JPHJ; Damen L; Donze SH; Juriaans AF; Kerkhof GF; Hokken-Koelega ACS
Eur J Endocrinol; 2021 May; 185(1):47-55. PubMed ID: 33886496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
